• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Elife . Leveraging mobility data to analyze persistent SARS-CoV-2 mutations and inform targeted genomic surveillance

tetano

Editor, Senior Moderator
Elife


. 2025 Jan 15:13:RP94045.
doi: 10.7554/eLife.94045. Leveraging mobility data to analyze persistent SARS-CoV-2 mutations and inform targeted genomic surveillance

Riccardo Spott[SUP] 1 [/SUP], Mathias W Pletz[SUP] 1 2 [/SUP], Carolin Fleischmann-Struzek[SUP] 1 2 [/SUP], Aurelia Kimmig[SUP] 1 [/SUP], Christiane Hadlich[SUP] 3 [/SUP], Matthias Hauert[SUP] 3 [/SUP], Mara Lohde[SUP] 1 [/SUP], Mateusz Jundzill[SUP] 1 [/SUP], Mike Marquet[SUP] 1 [/SUP], Petra Dickmann[SUP] 4 [/SUP], Ruben Schüchner[SUP] 5 [/SUP], Martin Hölzer[SUP] 6 [/SUP], Denise Kühnert[SUP] 7 8 [/SUP], Christian Brandt[SUP] 1 9 [/SUP]



Affiliations
Abstract

Given the rapid cross-country spread of SARS-CoV-2 and the resulting difficulty in tracking lineage spread, we investigated the potential of combining mobile service data and fine-granular metadata (such as postal codes and genomic data) to advance integrated genomic surveillance of the pandemic in the federal state of Thuringia, Germany. We sequenced over 6500 SARS-CoV-2 Alpha genomes (B.1.1.7) across 7 months within Thuringia while collecting patients' isolation dates and postal codes. Our dataset is complemented by over 66,000 publicly available German Alpha genomes and mobile service data for Thuringia. We identified the existence and spread of nine persistent mutation variants within the Alpha lineage, seven of which formed separate phylogenetic clusters with different spreading patterns in Thuringia. The remaining two are subclusters. Mobile service data can indicate these clusters' spread and highlight a potential sampling bias, especially of low-prevalence variants. Thereby, mobile service data can be used either retrospectively to assess surveillance coverage and efficiency from already collected data or to actively guide part of a surveillance sampling process to districts where these variants are expected to emerge. The latter concept was successfully implemented as a proof-of-concept for a mobility-guided sampling strategy in response to the surveillance of Omicron sublineage BQ.1.1. The combination of mobile service data and SARS-CoV-2 surveillance by genome sequencing is a valuable tool for more targeted and responsive surveillance.

Keywords: SARS-CoV-2; WGS; cluster tracking; epidemiology; global health; mobility data; nanopore sequencing; viruses.

 
Back
Top Bottom